Warning: Use of undefined constant custom_pagination - assumed 'custom_pagination' (this will throw an Error in a future version of PHP) in /home/customer/www/inmunotek.com/public_html/wp-content/themes/enfold/functions.php on line 1022

Corporate News

INMUNOTEK at SPAP Digital 2021

May 2021

INMUNOTEK has participated in the SPAP (Portuguese Society of Pediatric Allergology) Digital Congress with the presentation "Trained immunity vaccines (TIbV) through mucosa against viral infections: the MV130 model" by Dr. Laura Conejero Hall.
More info

INMUNOTEK at the XLV Congress of SEICAP

May 2021

INMUNOTEK has participated in the XLV Congress of the SEICAP (Spanish Society of Clinical Immunology, Allergology and Pediatric Asthma) in the session "Meeting with the Expert" entitled "Mite allergens and their cross-reactivity. From scientific evidence to real practice in pediatric patients".
More info

INMUNOTEK Symposium at the 42nd SEI Congress

March 2021

Within the 42nd congress of the SEI (Spanish Society of Immunology) INMUNOTEK has organized a satellite symposium on trained immunity-based vaccines (TIbV) that act through mucosa and their potential role against respiratory infections of viral origin.
More info

Industrial doctorates in the Community of Madrid

Comunidad MadridFebruary 2021

The Department of Science, Universities and Innovation of the Community of Madrid, has held a meeting with INMUNOTEK to evaluate the industrial doctorate program. This program is an initiative of the executive of the Community of Madrid to promote public-private collaboration through the completion of doctoral theses in an academic and business environment.
More info

INMUNOTEK listed in the 2020 edition of CEPYME500

cepyme500 2020December 2020

INMUNOTEK listed in CEPYME500, 2020 edition. This is an initiative of CEPYME (State Confederation of Small and Medium Enterprises) to identify, recognize and support the 500 leading companies in business growth in Spain. INMUNOTEK was already listed in 2017.
More info